Health for all
As a science-led global healthcare company we have the opportunity to improve the health and well-being of millions of people around the world.
Through investment in R&D and infrastructure, and through collaboration with others, we are innovating to address currently unmet health needs. We are improving access to our products, irrespective of where people live or their ability to pay, and we are working to control or eliminate diseases affecting the world’s most vulnerable people.
Discover more...
Access to healthcare
We are actively seeking new ways of delivering healthcare and making our products more available and affordable - find out more.
Tackling diseases in developing countries
Find out how we are tackling diseases like malaria, lymphatic filariasis and intestinal worms through donations of medicines, financial and practical support.
HIV, AIDS and ViiV Healthcare
Learn about ViiV Healthcare – an independent company established by GSK and Pfizer in 2009, that is 100% focused on the needs of people living with HIV.
Health and well-being in our communities
We aim to make a difference to communities through economic contribution, investment, education programmes and partnerships – find out more.
20% reinvestment
In the world’s Least Developed Countries we have committed to reinvest 20% of our profits back in to improving the healthcare infrastructure in those countries.
Our commitments
A list of our forward-looking commitments around Health for all.